Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients. Clinics, [S. l.], v. 72, n. 5, p. 317–324, 2017. DOI: 10.6061/clinics/2017(05)10. Disponível em: https://revistas.usp.br/clinics/article/view/133343.. Acesso em: 4 may. 2024.